Navigation Links
Isis to Receive Up to $14 Million from Pfizer for Its Acquisition of Excaliard Pharmaceuticals
Date:11/22/2011

CARLSBAD, Calif., Nov. 22, 2011 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that it will receive up to $14 million from Pfizer Inc. (NYSE: PFE) for its equity ownership of Excaliard Pharmaceuticals, Inc. from Pfizer's acquisition of Excaliard.  Upon closing of the acquisition, Isis will receive an initial $4.4 million.  Contingent payments of up to an additional $9.6 million could be paid to Isis upon achievement of various milestones associated with the clinical and commercial progress of EXC 001.  In addition, Isis will continue to be eligible for milestone and royalty payments under its licensing agreement with Excaliard for EXC 001.  The acquisition of Excaliard by Pfizer exemplifies the potential of Isis' strategy to partner antisense drugs in diseases that are outside of Isis' main therapeutic areas of focus and benefit financially from these partnerships.

"Our business strategy allows us to exploit our antisense drug discovery platform to create many opportunities outside of our core areas of therapeutic focus.  We have been extremely successful in implementing this unique strategy.  To date, we have generated more than $450 million from our satellite company partners.  Our partnership with Excaliard and their development of EXC 001 is the most recent example of the success of this strategy," said B. Lynne Parshall, J.D., Chief Operating Officer, Chief Financial Officer and Secretary at Isis.  "The local treatment of fibrosis for scarring is an area outside our key focus and, as such, is not one we would have pursued internally.  We chose instead to partner with Excaliard, a company with focused therapeutic expertise in this area.  Using its own resources and expertise, Excaliard has rapidly advanced EXC 001 to
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Sundia Receives 2011 Zero2IPO Venture 50 Award
2. Amsterdam Molecular Therapeutics Receives Orphan Designation in the European Union for Hemophilia B Gene Therapy
3. Vascular Designs, Inc. Receives CE Mark Approval for Its IsoFlow™ Infusion Catheter to Target Cancerous Tumors
4. Qualitest Pharmaceuticals Receives FDA Approval for Acetaminophen and Codeine Phosphate Oral Solution USP, 120mg/12mg per 5mL
5. First Patient Receives FDA-Approved Telescope Implant for End-Stage Macular Degeneration
6. Ethicon Endo-Surgery Receives 510(k) Clearance for New ENSEAL® G2 Curved and Straight Tissue Sealers Line -- Broadest Range of Advanced Bipolar Tissue Sealers Available for Open and Minimally Invasive Surgery
7. Nephros Receives Initial FDA Response to 510(k) Application for Hemodiafiltration System
8. New Web Technology Now Allows for Pharmaceutical Reps to Receive Training on Their Desktops, Tablets, and Smartphones
9. IDEV Technologies Receives FDA Clearance for Its SUPERA VERITAS® 6 French Stent Delivery System
10. Augurix Diagnostics Receives the 2011 Debiopharm /Valais Award for its Point-of-care Diagnostic Test for the Early Detection of Celiac Disease
11. The Childrens Hospital of Philadelphia Receives Grand Challenges Explorations Funding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... THOUSAND OAKS, Calif. , May 22, ... today announced the Company has commenced termination ... commercialization of brodalumab with AstraZeneca (LON:AZN, STO:AZN ... investigational IL-17 inhibitor, is in development for ... and axial spondyloarthritis.  The decision was based ...
(Date:5/22/2015)... 2015 /CNW/ - More than fifty years ago, Thalidomide was ... in expectant mothers. Tragically, Thalidomide caused serious and permanent physical ... Support has been provided to survivors over the years ... Canada in 1991 and settlements from drug companies. ... obligation to provide support, we have a clear moral obligation ...
(Date:5/22/2015)...  BioLife Solutions, Inc. (NASDAQ: BLFS ), a leading ... storage and cryopreservation freeze media and ... or the "Company"), announced that the Company is scheduled to ... The Company is scheduled to present at the Conference at ... Grand Hyatt Hotel in New York City ...
Breaking Medicine Technology:Amgen to terminate participation in co-development and commercialization of brodalumab 2Amgen to terminate participation in co-development and commercialization of brodalumab 3Amgen to terminate participation in co-development and commercialization of brodalumab 4Amgen to terminate participation in co-development and commercialization of brodalumab 5Statement from Minister Ambrose on Thalidomide 2Statement from Minister Ambrose on Thalidomide 3BioLife Solutions To Present At The 2015 Marcum MicroCap Conference In New York City 2
... BSN, OCN, an outpatient oncology clinical coordinator, became the ... community for health extenders, educators, and other professionals. ... crucial to being the best nurse I can be. ... healthcare professionals, experiences and utilizing the resources they have ...
... Uroplasty, Inc. (NASDAQ: UPI ), a medical device ... treat voiding dysfunctions, announced today that David Kaysen, President and ... the Company,s business strategy and financial results at the 24th ... 12, 2012 at The Ritz Carlton Laguna Niguel in Dana ...
Cached Medicine Technology:SurroundHealth Online Community Reaches 1,000 Members 2SurroundHealth Online Community Reaches 1,000 Members 3Uroplasty to Present at the 24th Annual ROTH Conference 2
(Date:5/23/2015)... Janesville, WI (PRWEB) May 23, 2015 ... Mercy Acceleration at the Sports Medicine and Rehabilitation Center, ... running clinic program, Mondays, June 1-July 20, 5:30-6:30 pm. ... MS, USAT coach, and Laurie Finke, RN, BSN, who ... flexibility exercises, education on nutrition, running mechanics and show ...
(Date:5/22/2015)... 2015 Pioneer Millworks, the largest reclaimed ... of designing with reclaimed wood, introducing their latest reclaimed ... California. Their newest offerings, Vat 35, Reclaimed Teak ... color to America's largest design event. , “Designers, architects, ... show, anxious to see and feel the variety of ...
(Date:5/22/2015)... York, New York (PRWEB) May 22, 2015 ... http://www.xareltolawsuit2015.com/ ) filed on behalf of individuals who ... due to its use continue to move forward ... Louisiana. According to a Pretrial Order dated May ... the preservation of documents and electronically stored information. ...
(Date:5/22/2015)... 2015 Hands On HealthCare Massage Therapy ... the Annual One Day Sale on Massage and ... HCMT offers drastically reduced certificates one day a year. This ... sessions, through what used to be the slowest time of ... community as well. This once a year occurrence has become ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 Coordinating ... a difficult process. Historically providers have not been ... payers. Starting in 2015, Medicare has paved the ... activities. Thanks to the launch of Oculus ... and health systems using the platform will now ...
Breaking Medicine News(10 mins):Health News:Pioneer Millworks to Reveal New Design Trends with Reclaimed Wood at Dwell on Design in LA 2Health News:Pioneer Millworks to Reveal New Design Trends with Reclaimed Wood at Dwell on Design in LA 3Health News:Court Overseeing Federal Xarelto Lawsuits Establishes Procedures Governing Preservation of Documents, Electronically Stored Information 2Health News:Court Overseeing Federal Xarelto Lawsuits Establishes Procedures Governing Preservation of Documents, Electronically Stored Information 3Health News:Court Overseeing Federal Xarelto Lawsuits Establishes Procedures Governing Preservation of Documents, Electronically Stored Information 4Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Announces Their Eighth Annual One Day Sale on Gift Certificates Will Take Place on June 17, 2015 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Announces Their Eighth Annual One Day Sale on Gift Certificates Will Take Place on June 17, 2015 3Health News:Oculus Health Care Coordination Platform Officially Launched 2Health News:Oculus Health Care Coordination Platform Officially Launched 3Health News:Oculus Health Care Coordination Platform Officially Launched 4
... HealthDay Reporter , MONDAY, Sept. 27 (HealthDay News) ... the metal mesh tubes used to keep clogged arteries ... came out on top, South Korean researchers report. ... the study found. Coating stents with time-released drugs ...
... Clinic researchers and their international colleagues have discovered genetic ... of women when taking aromatase inhibitors to treat their ... that many women halt their lifesaving medication. The findings ... of Clinical Oncology . "Many women stop taking ...
... and close friends are more sensitive to early signs ... researchers at Washington University School of Medicine in St. ... having memory problems by testing them with a variety ... words or comparing shapes of objects. Washington University researchers ...
... 2010) Virginia Commonwealth University School of Medicine and ... impotence drug Viagra, in combination with doxorubicin, a powerful ... while alleviating the damage to the heart at the ... decades the chemotherapeutic agent doxorubicin has been used to ...
... - The National Cancer Institute has awarded a five-year, ... at Chapel Hill,s Carolina Center of Cancer Nanotechnology Excellence ... for research to improve the diagnosis and treatment of ... support the continued work of the center launched in ...
... continuing in Afghanistan, UCLA has helped develop a first-of-its-kind ... in critical combat casualty care. The program will not ... but civilian care as well. Based ... Operation Iraqi Freedom and Operation Enduring Freedom in Afghanistan, ...
Cached Medicine News:Health News:In Test of Stents, Old Standby Wins Out 2Health News:Mayo collaboration finds source of breast drug side effect 2Health News:Friends, family detect early Alzheimer's signs better than traditional tests 2Health News:Friends, family detect early Alzheimer's signs better than traditional tests 3Health News:VCU study: Researchers discover a drug combination that shrinks tumors in vivo 2Health News:NCI awards $13.6 million to UNC's Carolina Center of Cancer Nanotechnology Excellence 2Health News:NCI awards $13.6 million to UNC's Carolina Center of Cancer Nanotechnology Excellence 3Health News:UCLA develops combat casualty care educational program for US armed forces 2Health News:UCLA develops combat casualty care educational program for US armed forces 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: